A retrospective study on Xpert MTB/RIF for detection of tuberculosis in a teaching hospital in China

Abstract Background The Xpert MTB/RIF assay is an automated molecular test that is designed to simultaneously detect Mycobacterium tuberculosis (MTB) complex and rifampin resistance. However, there are relatively few studies on this method in China. Xpert has been routinely used at Peking University...

Full description

Bibliographic Details
Main Authors: Shuguang Li, Liyan Lin, Feifei Zhang, Chunjiang Zhao, Han Meng, Hui Wang
Format: Article
Language:English
Published: BMC 2020-05-01
Series:BMC Infectious Diseases
Subjects:
Online Access:http://link.springer.com/article/10.1186/s12879-020-05004-8
id doaj-abc99e4434974f56b24e0dbf6bf25b3f
record_format Article
spelling doaj-abc99e4434974f56b24e0dbf6bf25b3f2020-11-25T02:06:06ZengBMCBMC Infectious Diseases1471-23342020-05-0120111110.1186/s12879-020-05004-8A retrospective study on Xpert MTB/RIF for detection of tuberculosis in a teaching hospital in ChinaShuguang Li0Liyan Lin1Feifei Zhang2Chunjiang Zhao3Han Meng4Hui Wang5Department of Clinical Laboratory, Peking University People’s HospitalDepartment of Clinical Laboratory, Peking University People’s HospitalDepartment of Clinical Laboratory, Peking University People’s HospitalDepartment of Clinical Laboratory, Peking University People’s HospitalDepartment of Clinical Laboratory, Peking University People’s HospitalDepartment of Clinical Laboratory, Peking University People’s HospitalAbstract Background The Xpert MTB/RIF assay is an automated molecular test that is designed to simultaneously detect Mycobacterium tuberculosis (MTB) complex and rifampin resistance. However, there are relatively few studies on this method in China. Xpert has been routinely used at Peking University People’s Hospital (PKUPH) since November 2016. Thus, the aim of this study was to evaluate the performance of Xpert, and provide a reference and guidance for the detection and diagnosis of TB in non-TB specialized hospitals. Methods The medical records of inpatients simultaneously tested with Xpert, acid-fast bacilli (AFB) smear microscopy, and interferon-gamma release assay (IGRA, by T-SPOT®.TB) at PKUPH from November 2016 to October 2018 were reviewed. Active TB cases were considered according to a composite reference standard (CRS). Then, the three methods were evaluated and compared. Results In total, 787 patients simultaneously tested with Xpert, AFB, and IGRA were enrolled; among them 11.3% (89/787) were diagnosed and confirmed active pulmonary TB (PTB, 52 cases), extrapulmonary TB (EPTB, 17 cases), and tuberculous pleurisy (TP, 20 cases). The sensitivity of Xpert in detecting PTB, EPTB, and TP was 88.5, 76.5, and 15.0%, respectively, which was slightly lower than IGRA (96.2, 82.4, and 95.0%, respectively), but higher than AFB (36.5, 11.8, and 0%, respectively); IGRA showed the highest sensitivity, but its specificity (55.9, 67.1, and 45.2%, respectively) was significantly lower than Xpert (99.6, 99.4, and 100%, respectively) and AFB (99.0, 99.4, and 100%, respectively) (P < 0.001). The sensitivity of Xpert in detecting lung tissue, cerebrospinal fluid, lymph nodes, and joint fluid was 100%, followed by sputum (88.5%), alveolar lavage (85.7%), and bronchoscopy secretion (81.2%); the pleural fluid sensitivity was the lowest, only 15.0%. For AFB negative patients, the sensitivity of Xpert in detecting PTB, EPTB, and TP was 84.9, 73.3, and 15.0%, respectively. Conclusions Xpert showed both high sensitivity and high specificity, and suggested its high value in TB diagnosis; however, the application of pleural fluid is still limited, and should be improved. Owing to the high sensitivity of IGRA, it is recommended for use as a supplementary test, especially for assisting in the diagnosis of TP and EPTB.http://link.springer.com/article/10.1186/s12879-020-05004-8Xpert MTB/RIFTuberculosisPulmonary tuberculosisExtra-pulmonary tuberculosisTuberculous pleurisy
collection DOAJ
language English
format Article
sources DOAJ
author Shuguang Li
Liyan Lin
Feifei Zhang
Chunjiang Zhao
Han Meng
Hui Wang
spellingShingle Shuguang Li
Liyan Lin
Feifei Zhang
Chunjiang Zhao
Han Meng
Hui Wang
A retrospective study on Xpert MTB/RIF for detection of tuberculosis in a teaching hospital in China
BMC Infectious Diseases
Xpert MTB/RIF
Tuberculosis
Pulmonary tuberculosis
Extra-pulmonary tuberculosis
Tuberculous pleurisy
author_facet Shuguang Li
Liyan Lin
Feifei Zhang
Chunjiang Zhao
Han Meng
Hui Wang
author_sort Shuguang Li
title A retrospective study on Xpert MTB/RIF for detection of tuberculosis in a teaching hospital in China
title_short A retrospective study on Xpert MTB/RIF for detection of tuberculosis in a teaching hospital in China
title_full A retrospective study on Xpert MTB/RIF for detection of tuberculosis in a teaching hospital in China
title_fullStr A retrospective study on Xpert MTB/RIF for detection of tuberculosis in a teaching hospital in China
title_full_unstemmed A retrospective study on Xpert MTB/RIF for detection of tuberculosis in a teaching hospital in China
title_sort retrospective study on xpert mtb/rif for detection of tuberculosis in a teaching hospital in china
publisher BMC
series BMC Infectious Diseases
issn 1471-2334
publishDate 2020-05-01
description Abstract Background The Xpert MTB/RIF assay is an automated molecular test that is designed to simultaneously detect Mycobacterium tuberculosis (MTB) complex and rifampin resistance. However, there are relatively few studies on this method in China. Xpert has been routinely used at Peking University People’s Hospital (PKUPH) since November 2016. Thus, the aim of this study was to evaluate the performance of Xpert, and provide a reference and guidance for the detection and diagnosis of TB in non-TB specialized hospitals. Methods The medical records of inpatients simultaneously tested with Xpert, acid-fast bacilli (AFB) smear microscopy, and interferon-gamma release assay (IGRA, by T-SPOT®.TB) at PKUPH from November 2016 to October 2018 were reviewed. Active TB cases were considered according to a composite reference standard (CRS). Then, the three methods were evaluated and compared. Results In total, 787 patients simultaneously tested with Xpert, AFB, and IGRA were enrolled; among them 11.3% (89/787) were diagnosed and confirmed active pulmonary TB (PTB, 52 cases), extrapulmonary TB (EPTB, 17 cases), and tuberculous pleurisy (TP, 20 cases). The sensitivity of Xpert in detecting PTB, EPTB, and TP was 88.5, 76.5, and 15.0%, respectively, which was slightly lower than IGRA (96.2, 82.4, and 95.0%, respectively), but higher than AFB (36.5, 11.8, and 0%, respectively); IGRA showed the highest sensitivity, but its specificity (55.9, 67.1, and 45.2%, respectively) was significantly lower than Xpert (99.6, 99.4, and 100%, respectively) and AFB (99.0, 99.4, and 100%, respectively) (P < 0.001). The sensitivity of Xpert in detecting lung tissue, cerebrospinal fluid, lymph nodes, and joint fluid was 100%, followed by sputum (88.5%), alveolar lavage (85.7%), and bronchoscopy secretion (81.2%); the pleural fluid sensitivity was the lowest, only 15.0%. For AFB negative patients, the sensitivity of Xpert in detecting PTB, EPTB, and TP was 84.9, 73.3, and 15.0%, respectively. Conclusions Xpert showed both high sensitivity and high specificity, and suggested its high value in TB diagnosis; however, the application of pleural fluid is still limited, and should be improved. Owing to the high sensitivity of IGRA, it is recommended for use as a supplementary test, especially for assisting in the diagnosis of TP and EPTB.
topic Xpert MTB/RIF
Tuberculosis
Pulmonary tuberculosis
Extra-pulmonary tuberculosis
Tuberculous pleurisy
url http://link.springer.com/article/10.1186/s12879-020-05004-8
work_keys_str_mv AT shuguangli aretrospectivestudyonxpertmtbriffordetectionoftuberculosisinateachinghospitalinchina
AT liyanlin aretrospectivestudyonxpertmtbriffordetectionoftuberculosisinateachinghospitalinchina
AT feifeizhang aretrospectivestudyonxpertmtbriffordetectionoftuberculosisinateachinghospitalinchina
AT chunjiangzhao aretrospectivestudyonxpertmtbriffordetectionoftuberculosisinateachinghospitalinchina
AT hanmeng aretrospectivestudyonxpertmtbriffordetectionoftuberculosisinateachinghospitalinchina
AT huiwang aretrospectivestudyonxpertmtbriffordetectionoftuberculosisinateachinghospitalinchina
AT shuguangli retrospectivestudyonxpertmtbriffordetectionoftuberculosisinateachinghospitalinchina
AT liyanlin retrospectivestudyonxpertmtbriffordetectionoftuberculosisinateachinghospitalinchina
AT feifeizhang retrospectivestudyonxpertmtbriffordetectionoftuberculosisinateachinghospitalinchina
AT chunjiangzhao retrospectivestudyonxpertmtbriffordetectionoftuberculosisinateachinghospitalinchina
AT hanmeng retrospectivestudyonxpertmtbriffordetectionoftuberculosisinateachinghospitalinchina
AT huiwang retrospectivestudyonxpertmtbriffordetectionoftuberculosisinateachinghospitalinchina
_version_ 1724935001992069120